Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Henderson YC
These sleep effects are also consistent with the pharmacokinetic profile of lorediplon
InChi: InChI=1S/C23H24N6/c1-16(2)20-6-4-5-7-21(20)23-24-14-17(3)22(27-23)25-15-18-8-10-19(11-9-18)29-13-12-26-28-29/h4-14
mean tumor numbers
ITD-1 - TGFβ inhibitor. CAS# 1099644-42-4 0281 Henderson YCITD 1, CAS No. 1099644 42 4, is a novel and highly selective TGF pathway inhibitor identified by a high throughput, embryonic stem cell (ESC) cardiac differentiation screening. ITD 1 promoted cardiomyocyte differentiation specifically via degradation of the TGF type II receptor (TGFBR2), effectively clearing the receptor from the cell surface and selectively inhibiting intracellular signaling (IC50 0. 40. 8 M), revealing a role for TGF signaling
US$ 305.51
US$ 147.83
US$ 110.28
US$ 366.29
US$ 157.56
US$ 126.47
US$ 105.49
US$ 141.26
US$ 118.16
US$ 63.50
US$ 404.05
US$ 157.56